Gerber Kawasaki Wealth & Investment Management Bristol Myers Squibb CO Transaction History

Gerber Kawasaki Wealth & Investment Management

  • $2.16 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$61.48 - $73.72 $252,682 - $302,989
-4,110 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$53.63 - $62.52 $42,314 - $49,328
789 Added 23.76%
4,110 $205,000
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $5,266 - $6,168
89 Added 2.75%
3,321 $196,000
Q2 2021

Aug 11, 2021
SELL
$61.91 - $67.42 $6,191 - $6,742
-100 Reduced 3.0%
3,232 $215,000
Q1 2021

May 07, 2021
BUY
$59.34 - $66.74 $197,720 - $222,377
3,332 New
3,332 $210,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gerber Kawasaki Wealth & Investment Management Portfolio

Follow Gerber Kawasaki Wealth & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email